| Hospital acquired pneumonia
Zerbaxa vs Fetroja
Side-by-side clinical, coverage, and cost comparison for hospital acquired pneumonia.Deep comparison between: Zerbaxa vs Fetroja with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsFetroja has a higher rate of injection site reactions vs Zerbaxa based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Fetroja but not Zerbaxa, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Zerbaxa
Fetroja
At A Glance
IV infusion
Every 8 hours
Cephalosporin/beta-lactamase inhibitor
IV infusion
Every 8 hours
Cephalosporin antibacterial
Indications
- Peritonitis
- Urinary tract infection
- Pyelonephritis
- Hospital acquired pneumonia
- VABP
- Complicated urinary tract infection
- Pyelonephritis
- Hospital acquired pneumonia
- Pneumonia, Ventilator-Associated
Dosing
Peritonitis 1.5 g IV every 8 hours over 1 hour for 4 to 14 days, used in conjunction with metronidazole 500 mg IV every 8 hours; pediatric patients: 30 mg/kg up to 1.5 g every 8 hours for 5 to 14 days.
Urinary tract infection, Pyelonephritis 1.5 g IV every 8 hours over 1 hour for 7 days; pediatric patients: 30 mg/kg up to 1.5 g every 8 hours for 7 to 14 days.
Hospital acquired pneumonia, VABP 3 g IV every 8 hours over 1 hour for 8 to 14 days in adult patients 18 years and older.
Complicated urinary tract infection, Pyelonephritis 2 grams IV infusion over 3 hours every 8 hours in adults with CLcr 60 to 119 mL/min; dose adjusted for CLcr <60 or >=120 mL/min; duration 7 to 14 days.
Hospital acquired pneumonia, Pneumonia, Ventilator-Associated 2 grams IV infusion over 3 hours every 8 hours in adults with CLcr 60 to 119 mL/min; dose adjusted for CLcr <60 or >=120 mL/min; duration 7 to 14 days.
Contraindications
- Known serious hypersensitivity to components of ZERBAXA (ceftolozane and tazobactam), piperacillin/tazobactam, or other members of the beta-lactam class
- Known history of severe hypersensitivity to cefiderocol, other beta-lactam antibacterial drugs, or any other component of FETROJA
Adverse Reactions
Most common (>=5%) Nausea, diarrhea, headache, pyrexia
Serious Hypersensitivity reactions, Clostridioides difficile-associated diarrhea, intracranial hemorrhage, renal impairment/renal failure, hepatic transaminase increased
Most common (>=2%) Diarrhea, elevations in liver tests, hypokalemia, infusion site reactions, constipation, rash, candidiasis, headache, nausea, vomiting, hypomagnesemia, atrial fibrillation
Serious Increase in all-cause mortality in carbapenem-resistant gram-negative bacterial infections, hypersensitivity reactions, Clostridioides difficile-associated diarrhea, seizures and other central nervous system adverse reactions
Postmarketing Neutropenia, chromaturia
Pharmacology
Ceftolozane is a cephalosporin antibacterial that inhibits bacterial cell wall biosynthesis by binding to penicillin-binding proteins (PBPs); tazobactam is an irreversible beta-lactamase inhibitor that extends ceftolozane activity against beta-lactamase-producing organisms.
Cefiderocol is a cephalosporin antibacterial that functions as a siderophore, using the bacterial iron uptake mechanism to traverse the outer cell membrane and exert bactericidal activity by inhibiting cell wall biosynthesis through binding to penicillin-binding proteins (PBPs).
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Zerbaxa
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (6/12) · Qty limit (0/12)
Fetroja
- Covered on 5 commercial plans
- PA (6/12) · Step Therapy (0/12) · Qty limit (0/12)
UnitedHealthcare
Zerbaxa
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Fetroja
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Humana
Zerbaxa
- Covered on 0 commercial plans
- PA (0/3) · Step Therapy (0/3) · Qty limit (0/3)
Fetroja
- Covered on 0 commercial plans
- PA (2/3) · Step Therapy (0/3) · Qty limit (2/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Zerbaxa.
No savings programs available for Fetroja.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
ZerbaxaView full Zerbaxa profile
FetrojaView full Fetroja profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.